BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9718525)

  • 1. Results from the Ontario breast screening program, 1990-1995.
    Libstug AR; Moravan V; Aitken SE
    J Med Screen; 1998; 5(2):73-80. PubMed ID: 9718525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
    Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
    Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organized breast screening improves reattendance compared to physician referral: a case control study.
    Makedonov I; Gu S; Paszat LF;
    BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
    Halapy EE; Chiarelli AM; Klar N; Knight J
    J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive result and reattendance in the Ontario Breast Screening Program.
    Chiarelli AM; Moravan V; Halapy E; Majpruz V; Mai V; Tatla RK
    J Med Screen; 2003; 10(3):129-33. PubMed ID: 14561264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of two view mammography compared with one view in the detection of small invasive cancers: further results from the National Health Service breast screening programme.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 1997; 4(2):98-101. PubMed ID: 9275268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.
    Blanks RG; Wallis MG; Moss SM
    J Med Screen; 1998; 5(4):195-201. PubMed ID: 9934650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor size distribution of invasive breast cancers and the sensitivity of screening methods in the Canadian National Breast Screening Study.
    Shaevitch D; Taghipour S; Miller AB; Montgomery N; Harvey B
    J Cancer Res Ther; 2017; 13(3):562-569. PubMed ID: 28862227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from 10 years of breast screening in Wales.
    Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S
    J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
    Bancej C; Decker K; Chiarelli A; Harrison M; Turner D; Brisson J
    J Med Screen; 2003; 10(1):16-21. PubMed ID: 12790311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 1996; 3(4):200-3. PubMed ID: 9041485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.
    Raikhlin A; Curpen B; Warner E; Betel C; Wright B; Jong R
    AJR Am J Roentgenol; 2015 Apr; 204(4):889-97. PubMed ID: 25794083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from the NHS breast screening programme 1990-1993.
    Moss SM; Michel M; Patnick J; Johns L; Blanks R; Chamberlain J
    J Med Screen; 1995; 2(4):186-90. PubMed ID: 8719146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.